TORONTO, Sept. 16, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”), a global leader in providing financing to advance innovation in the life sciences industry, today announced that it will present at the following investor conferences in September and October:
24th Annual CIBC Eastern Institutional Investor Conference
Date: September 25, 2025
Presentation time: 4:00 p.m. ET.
City: Montreal, Quebec
Raymond James Dividend & Royalty Conference
Date: October 1, 2025
Presentation time: 12:00 p.m. ET.
City: Toronto, Ontario
About DRI Healthcare Trust
DRI Healthcare is a pioneer in global pharmaceutical royalty monetization. Since our founding in 1989, we have deployed more than $3.0 billion, acquiring more than 75 royalties on 45-plus drugs, including Ekterly (sebetralstat), Eylea, Keytruda, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga. DRI Healthcare’s units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol “DHT.UN” and in U.S. dollars under the symbol “DHT.U”. To learn more, visit drihealthcare.com or follow us on LinkedIn.
SOURCE DRI Healthcare Trust
For further information, please contact: David Levine, Director, Investor Relations, Tel: (416) 324-5738, ir@drihealthcare.com